Search research articles
Contact Us
Filters
Showing results (1-10 of 62) with videos related to
Page
of 7
Sort By:
Psychotherapie, Psychosomatik, Medizinische Psychologie
|
January 14, 2005
[The immunology of psychiatric disorders]
Volker Arolt, Matthias Rothermundt
Advances in Psychosomatic Medicine
|
August 26, 2004
Depression in medical patients
Volker Arolt, Matthias Rothermundt
Handbook of Clinical Neurology
|
May 22, 2012
Clinical psychoneuroimmunology
Michael R Irwin, Matthias Rothermundt
International Review of Neurobiology
|
March 10, 2004
S100B in schizophrenic psychosis
Matthias Rothermundt, Gerald Ponath, Volker Arolt
General Physiology and Biophysics
|
January 23, 2010
S100B in schizophrenia: an update
Matthias Rothermundt, Jan Niklas Ahn, Silke Jörgens
Microscopy Research and Technique
|
March 20, 2003
S100B in brain damage and neurodegeneration
Matthias Rothermundt, Marion Peters, Jochen H M Prehn, et al.
Neuropsychobiology
|
February 5, 2003
The influence of typical and atypical neuroleptic drugs in the production of interleukin-2 and interferon-gamma in vitro
Sebastian Rudolf, Marion Peters, Matthias Rothermundt, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
March 5, 2004
S100B serum levels and long-term improvement of negative symptoms in patients with schizophrenia
Matthias Rothermundt, Gerald Ponath, Thomas Glaser, et al.
Journal of Geriatric Psychiatry and Neurology
|
February 7, 2009
Association between cytokines and cerebral MRI changes in the aging brain
Bernhard T Baune, Gerald Ponath, Matthias Rothermundt, et al.
Neuroscience Letters
|
July 22, 2008
Distinct regulation of brain-derived neurotrophic factor and noradrenaline in S100B knockout mice
Olaf Schulte-Herbrüggen, Heide Hörtnagl, Gerald Ponath, et al.
Page
of 7
Search research articles
Search
Showing results (1-10 of 62) with videos related to
Sort By:
Page
of 7
Psychotherapie, Psychosomatik, Medizinische Psychologie
|
January 14, 2005
[The immunology of psychiatric disorders]
Volker Arolt, Matthias Rothermundt
Advances in Psychosomatic Medicine
|
August 26, 2004
Depression in medical patients
Volker Arolt, Matthias Rothermundt
Handbook of Clinical Neurology
|
May 22, 2012
Clinical psychoneuroimmunology
Michael R Irwin, Matthias Rothermundt
International Review of Neurobiology
|
March 10, 2004
S100B in schizophrenic psychosis
Matthias Rothermundt, Gerald Ponath, Volker Arolt
General Physiology and Biophysics
|
January 23, 2010
S100B in schizophrenia: an update
Matthias Rothermundt, Jan Niklas Ahn, Silke Jörgens
Microscopy Research and Technique
|
March 20, 2003
S100B in brain damage and neurodegeneration
Matthias Rothermundt, Marion Peters, Jochen H M Prehn, et al.
Neuropsychobiology
|
February 5, 2003
The influence of typical and atypical neuroleptic drugs in the production of interleukin-2 and interferon-gamma in vitro
Sebastian Rudolf, Marion Peters, Matthias Rothermundt, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
March 5, 2004
S100B serum levels and long-term improvement of negative symptoms in patients with schizophrenia
Matthias Rothermundt, Gerald Ponath, Thomas Glaser, et al.
Journal of Geriatric Psychiatry and Neurology
|
February 7, 2009
Association between cytokines and cerebral MRI changes in the aging brain
Bernhard T Baune, Gerald Ponath, Matthias Rothermundt, et al.
Neuroscience Letters
|
July 22, 2008
Distinct regulation of brain-derived neurotrophic factor and noradrenaline in S100B knockout mice
Olaf Schulte-Herbrüggen, Heide Hörtnagl, Gerald Ponath, et al.
Page
of 7